Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey Read more →
Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO Read more →
Icon inks Anthropic partnership to deploy Claude into clinical trials Read more →
